Indivior Share Discussion Threads

[rafieh] 18/3/2019 13:29

If you are on about Reddy asking for compensation for taking out injunction, this has been discussed here before.

[essentialinvestor] 18/3/2019 13:24

You really need to ask that ?.

[rafieh] 18/3/2019 13:22

What claims exactly?

[essentialinvestor] 18/3/2019 13:17

Are the provisions to cover potential litigation on opioid related claims
adequate?.

[rafieh] 18/3/2019 13:08

This is what I mean. It gyrates wildly and you need to hold your nerves and go long and then short at the right time. I am almost certain it will close near the lows today and will start to recover over the next couple of days. Go long at the closing bell today if it reaches 100p mark, and you will be able to close the position before the end of the week. That's what I will be doing. No advice intended. DYOR.

[dealy] 18/3/2019 12:47

what the hell is wrong now? down 10% in 2 days

[rafieh] 07/3/2019 13:08

This is an excellent share for short term trading. Don't get me wrong though, I am invested here for long term too, but the wide range of fluctuations makes it a great share to play with.

[dealy] 07/3/2019 09:43

this is going up now

[dealy] 28/2/2019 17:07

UK market is full of undervalued companies like this. Standard Life just increased to over 17%. They know a bargain

[the grumpy old men] 27/2/2019 15:09

Oliver Haill
Sharecast News
27 Feb, 2019 14:48
Indivior launches schizophrenia treatment in US
perseris indivior
Indivior
104.30
14:51:16 27/02/19
-0.43%
-0.45

Indivior has launched its monthly injectable treatment for adult schizophrenia in the US, for which it has guided to peak sales of $200-300m.
FTSE 250
19,158.42
14:52:29 27/02/19
-0.58%
-112.26
FTSE 350
3,955.03
14:52:29 27/02/19
-0.60%
-23.75
FTSE All-Share
3,903.38
14:52:30 27/02/19
-0.57%
-22.52

Perseris is an extended-release injectable formulation containing the commonly prescribed active ingredient risperidone, which received approval by the US drug regulator last year. The company has said it will market the drug with a sales force consisting of roughly 50 staff.

A severe mental disorder characterised by acute psychotic episodes, schizophrenia is estimated to affect 23m people worldwide and requires ongoing management. Symptoms can include delusions, hallucinations, social withdrawal, avolition, impaired sustained attention and working memory, anxiety and depression, hostility and aggression, and increased risk of suicide.

Noting that many sufferers are unable to perceive their illness and can therefore stop taking their medication, Indivior developed this long-acting formulation to provide patients with steady concentrations of the active drug over the course of a month.

"Schizophrenia is a complex disease and part of the complexity is that a patient may not recognize that they are ill and therefore not see the need to take medicine," said Invidior chief medical officer, Anne Andorn.

She added that reducing the symptoms of schizophrenia "is very important to help reduce the abnormal behaviors that can lead to the stigma of this disease".

Perseris, which has to be administered by a doctor or nurse, is injected under the skin into a large muscle such as the buttock or shoulder where it forms a 'depot' of the drug that is released over an entire month.

Like all anti-psychotic drugs, risperidone blocks dopamine to decrease psychotic behaviour, but it also blocks serotonin, which makes it more effective in treatment of bipolar disorder and other conditions like aggression in autism.

[sidny1] 22/2/2019 11:50

Your not alone RafiehHoping for above 10p too by today

[rafieh] 22/2/2019 11:19

Well, we may go above 110p Mark, even as early as today!

[rafieh] 22/2/2019 08:25

Buyers are coming out of the woodwork.

[rafieh] 21/2/2019 15:16

Will be back above 110 next week easily.

[rafieh] 21/2/2019 15:11

Time to top up guys. It usually bounces back from these levels.

[dealy] 20/2/2019 08:52

company has about 500m GBP of net cash if I am not mistaken

[pre] 20/2/2019 08:19

Good news this morning on the product launch...some bigger buys coming in.

[waldron] 20/2/2019 08:19

Frank Prenesti
Sharecast News
20 Feb, 2019 08:05 20 Feb, 2019 08:05
Indivior to release generic version of opioid drug after losing court battle
Indivior
106.75
08:03:15 20/02/19
-7.82%
1.95

Indivior said it was releasing an authorised generic version of its Suboxone opiod addiction treatment in the US after losing a court bid to stop a copycat version made by India-based rival Dr. Reddy’s Laboratories.
FTSE 250
19,043.00
08:03:23 20/02/19
-0.14%
-25.89
FTSE 350
3,992.41
08:03:22 20/02/19
0.19%
7.42
FTSE All-Share
3,938.40
08:03:19 20/02/19
0.17%
6.63

The US Supreme Court on Tuesday cleared the way for a cut-price version of Indivior's Suboxone Film.

Chief executive Shaun Thaxter said the company was making an the generic drug available to patients and providers immediately, “giving them yet another option of medication-assisted treatment for opioid dependence”.

“In addition, we expect this launch will create the opportunity to maximize the value of our Suboxone Film franchise,” he said.

“With the launch of this authorized generic by Indivior, it is possible that other companies may also launch their own generic versions of Suboxone Film.”

The company’s authorized generic is being marketed and distributed by Sandoz.

[rafieh] 20/2/2019 07:18

Lindowcross,Another RNS out today, in which the company refers to the legal dispute, but there is no indication of compensation being expected from INDV because of previous injunction.I shouldn't worry about that.

[rafieh] 19/2/2019 17:48

I don't know the answer, but I'd expect the market to know. If after 2 weeks of the ruling, the share price is still above the support line, then the likely consequences are already factored in the price, I should think.

[lindowcross] 19/2/2019 17:07

I currently don't have a holding in this but I did, and I'm interested in the company. I haven't read the RNS's but, on the face of it, pwhite73 was correct to state Indivior will have to pay damages to Dr Reddy's. In the UK to get an interlocutory injunction like this you have to give an undertaking to the court to pay for the losses suffered by the injuncted party, if it later turns out you lose and so were not entitled to the protection of the injunction. I understand in the USA sometimes you have to post a bond to cover the same risk. Does anyone know if the company has made any comment about a claim from Dr Reddy's for damages?

[rafieh] 19/2/2019 14:04

This will bounce off low 100s again. Get ready to top up/buy in there.

[rafieh] 18/2/2019 08:44

So much for Jeffries target price!

[waldron] 18/2/2019 07:05

Jefferies target price reduced from 118 to 114 GBp.

[steeplejack] 14/2/2019 17:48

Even a stopped clock tells the right time twice a day!